These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34496447)

  • 21. Economic burden and mental health of primary caregivers of perinatally HIV infected adolescents from Kilifi, Kenya.
    Katana PV; Abubakar A; Nyongesa MK; Ssewanyana D; Mwangi P; Newton CR; Jemutai J
    BMC Public Health; 2020 Apr; 20(1):504. PubMed ID: 32299411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Burden of disease study of overweight and obesity; the societal impact in terms of cost-of-illness and health-related quality of life.
    Hecker J; Freijer K; Hiligsmann M; Evers SMAA
    BMC Public Health; 2022 Jan; 22(1):46. PubMed ID: 34996413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.
    Wiles N; Thomas L; Abel A; Barnes M; Carroll F; Ridgway N; Sherlock S; Turner N; Button K; Odondi L; Metcalfe C; Owen-Smith A; Campbell J; Garland A; Hollinghurst S; Jerrom B; Kessler D; Kuyken W; Morrison J; Turner K; Williams C; Peters T; Lewis G
    Health Technol Assess; 2014 May; 18(31):1-167, vii-viii. PubMed ID: 24824481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychotherapy for Major Depressive Disorder and Generalized Anxiety Disorder: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2017; 17(15):1-167. PubMed ID: 29213344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burden of mental health problems: quality of life and cost-of-illness in youth consulting Dutch walk-in youth health centres.
    Leijdesdorff SMJ; Huijs CEM; Klaassen RMC; Popma A; van Amelsvoort TAMJ; Evers SMAA
    J Ment Health; 2023 Feb; 32(1):150-157. PubMed ID: 33086874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study.
    Chuvarayan Y; Finger RP; Köberlein-Neu J
    Eur J Health Econ; 2020 Feb; 21(1):115-127. PubMed ID: 31493181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Societal burden of clinically anxious youth referred for treatment: a cost-of-illness study.
    Bodden DH; Dirksen CD; Bögels SM
    J Abnorm Child Psychol; 2008 May; 36(4):487-97. PubMed ID: 18214667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2019; 19(6):1-199. PubMed ID: 30873251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness and Cost-Effectiveness of Blended Cognitive Behavioral Therapy in Clinically Depressed Adolescents: Protocol for a Pragmatic Quasi-Experimental Controlled Trial.
    Rasing SPA; Stikkelbroek YAJ; Riper H; Dekovic M; Nauta MH; Dirksen CD; Creemers DHM; Bodden DHM
    JMIR Res Protoc; 2019 Oct; 8(10):e13434. PubMed ID: 31593538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-Utility Analysis of Mindfulness-Based Cognitive Therapy Versus Antidepressant Pharmacotherapy for Prevention of Depressive Relapse in a Canadian Context: Analyse coût-utilité de la thérapie cognitive basée sur la pleine conscience contre la pharmacothérapie antidépressive pour prévenir la rechute de la dépression en contexte canadien.
    Pahlevan T; Ung C; Segal Z
    Can J Psychiatry; 2020 Aug; 65(8):568-576. PubMed ID: 32031000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cost of lost productivity due to premature cancer-related mortality: an economic measure of the cancer burden.
    Hanly PA; Sharp L
    BMC Cancer; 2014 Mar; 14():224. PubMed ID: 24670067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.
    Richards DA; Rhodes S; Ekers D; McMillan D; Taylor RS; Byford S; Barrett B; Finning K; Ganguli P; Warren F; Farrand P; Gilbody S; Kuyken W; O'Mahen H; Watkins E; Wright K; Reed N; Fletcher E; Hollon SD; Moore L; Backhouse A; Farrow C; Garry J; Kemp D; Plummer F; Warner F; Woodhouse R
    Health Technol Assess; 2017 Aug; 21(46):1-366. PubMed ID: 28857042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The societal cost of depression: evidence from 10,000 Swedish patients in psychiatric care.
    Ekman M; Granström O; Omérov S; Jacob J; Landén M
    J Affect Disord; 2013 Sep; 150(3):790-7. PubMed ID: 23611536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing Costs Using the Treatment Inventory Cost in Psychiatric Patients (TIC-P), TIC-P Mini and TIC-P Midi.
    Kanters TA; Timman R; Zijlstra-Vlasveld MC; Muntingh A; Huijbregts KM; van Steenbergen-Weijenburg KM; Bouwmans CAM; van der Feltz-Cornelis CM; Hakkaart-van Roijen L
    J Ment Health Policy Econ; 2019 Mar; 22(1):15-24. PubMed ID: 30991352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Septoplasty versus non-surgical management for nasal obstruction in adults with a deviated septum: economic evaluation alongside a randomized controlled trial.
    van Egmond MMHT; Grutters JPC; Hannink G; van Heerbeek N; Rovers MM
    BMC Med; 2020 May; 18(1):101. PubMed ID: 32354362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness, relapse prevention and mechanisms of change of cognitive therapy vs. interpersonal therapy for depression: Study protocol for a randomised controlled trial.
    Lemmens LH; Arntz A; Peeters FP; Hollon SD; Roefs A; Huibers MJ
    Trials; 2011 Jun; 12():150. PubMed ID: 21672217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care.
    Stant AD; TenVergert EM; Kluiter H; Conradi HJ; Smit A; Ormel J
    J Ment Health Policy Econ; 2009 Dec; 12(4):195-204. PubMed ID: 20195007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness analysis of cognitive behaviour therapy for treatment of minor or mild-major depression in elderly patients with type 2 diabetes: study protocol for the economic evaluation alongside the MIND-DIA randomized controlled trial (MIND-DIA CEA).
    Chernyak N; Petrak F; Plack K; Hautzinger M; Müller MJ; Giani G; Icks A
    BMC Geriatr; 2009 Jul; 9():25. PubMed ID: 19570236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-utility of a guided Internet-based intervention in comparison with attention only for people with HIV and depressive symptoms: A randomized controlled trial.
    van Luenen S; Kraaij V; Garnefski N; Spinhoven P; van den Akker-van Marle ME
    J Psychosom Res; 2019 Mar; 118():34-40. PubMed ID: 30782352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.